Beispiel: Heart Attack

Klinische Studien gesponsert von BioInvent International AB

Insgesamt 15 ergebnisse

NCT04752826

Rekrutierung

BI-1808 as a Single Agent and With Pembrolizumab in Treatment of Advanced Malignancies

Bedingungen: Advanced Malignancies
NCT04219254

Rekrutierung

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors (KEYNOTE-A04)

Bedingungen: Solid Tumor, Adult
NCT03571568

Rekrutierung

A Study of BI-1206 in Combination With Rituximab in Subjects With Indolent B-Cell Non-Hodgkin Lymphoma

Bedingungen: Indolent B-Cell Non-Hodgkin Lymphoma
NCT02756728

Beendet

A Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple Myeloma

Bedingungen: Multiple Myeloma
NCT01838369

Beendet

A Phase II Study of BI-505 in Smoldering Multiple Myeloma

Bedingungen: Smoldering Multiple Myeloma
NCT01486823

Abgeschlossen

Bioavailability Study of MLDL1278A After Subcutaneous and Intravenous Administration in Healthy Subjects

Bedingungen: Healthy
NCT01025206

Abgeschlossen

A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myeloma

Bedingungen: Multiple Myeloma
NCT00702494

Abgeschlossen

Phase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid Tumours

Bedingungen: Solid Tumors
NCT04725331

Noch nicht rekrutiert

A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors

Bedingungen: Solid Tumor, Adult; Metastatic Cancer; Soft Tissue Sarcoma; Merkel Cell Carcinoma; Melanoma; Triple Negative Breast Cancer; Non Small Cell Lung Cancer
NCT01344954

Abgeschlossen

Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery

Bedingungen: Prophylaxis of Venous Thromboembolic Events
NCT01258907

Abgeschlossen

A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER)

Bedingungen: Atherosclerosis
NCT00618579

Abgeschlossen

Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin

Bedingungen: Healthy
NCT00612417

Abgeschlossen

Effect of Recombinant FVIII in Healthy Male Subjects Treated With TB-402

Bedingungen: Healthy
NCT00612196

Abgeschlossen

A Phase I Study of Monoclonal Antibody TB-402 in Healthy Male Volunteers

Bedingungen: Healthy
NCT00793234

Abgeschlossen

Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery

Bedingungen: Total Knee Replacement Surgery